SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001753926-20-000100
Filing Date
2020-05-06
Accepted
2020-05-06 14:19:04
Documents
1
Group Members
BROWN STONE CAPITAL, LPSILVER ROCK ASSOCIATES, INC.

Document Format Files

Seq Description Document Type Size
1 SC 13D g081968_sch13d.htm SC 13D 82295
  Complete submission text file 0001753926-20-000100.txt   83858
Mailing Address 23046 AVENIDA DE LA CARLOTA, SUITE 600 LAGUNA HILLS CA 92653
Business Address 23046 AVENIDA DE LA CARLOTA, SUITE 600 LAGUNA HILLS CA 92653 (917) 595.2850
PharmaCyte Biotech, Inc. (Subject) CIK: 0001157075 (see all company filings)

IRS No.: 621772151 | State of Incorp.: NV | Fiscal Year End: 0430
Type: SC 13D | Act: 34 | File No.: 005-91495 | Film No.: 20852177
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 9663 SANTA MONICA BLVD. NO. 1091 BEVERLY HILLS CA 90210
Business Address
Montazeri Nima (Filed by) CIK: 0001811031 (see all company filings)

Type: SC 13D